These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9804512)

  • 21. Novacor left ventricular assist system versus Heartmate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study.
    El-Banayosy A; Arusoglu L; Kizner L; Tenderich G; Minami K; Inoue K; Körfer R
    J Thorac Cardiovasc Surg; 2000 Mar; 119(3):581-7. PubMed ID: 10694620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of panel-reactive antibodies by treatment with mycophenolate mofetil.
    Schmid C; Garritsen HS; Kelsch R; Cassens U; Baba HA; Sibrowski W; Scheld HH
    Thorac Cardiovasc Surg; 1998 Jun; 46(3):161-2. PubMed ID: 9714495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bridge to cardiac transplantation: current practice.
    Nastala CJ
    Crit Care Nurs Q; 1995 May; 18(1):65-76. PubMed ID: 7719949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization.
    Drakos SG; Kfoury AG; Kotter JR; Reid BB; Clayson SE; Selzman CH; Stehlik J; Fisher PW; Merida M; Eckels DD; Brunisholz K; Horne BD; Stoker S; Li DY; Renlund DG
    J Heart Lung Transplant; 2009 Aug; 28(8):838-42. PubMed ID: 19632582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome?
    Massad MG; McCarthy PM; Smedira NG; Cook DJ; Ratliff NB; Goormastic M; Vargo RL; Navia J; Young JB; Stewart RW
    J Thorac Cardiovasc Surg; 1996 Nov; 112(5):1275-81; discussion 1282-3. PubMed ID: 8911324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival.
    Cleveland JC; Grover FL; Fullerton DA; Campbell DN; Mitchell MB; Lindenfeld J; Wolfel EE; Lowes BD; Shakar SF; Brieke A; Cannon A; Robertson AD
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):774-7. PubMed ID: 18805284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA sensitization in pediatric pre-transplant cardiac patients supported by mechanical assist devices: the utility of Luminex.
    Yang J; Schall C; Smith D; Kreuser L; Zamberlan M; King K; Gajarski R
    J Heart Lung Transplant; 2009 Feb; 28(2):123-9. PubMed ID: 19201336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HeartMate left ventricular assist device as bridge to heart transplantation.
    Koul B; Solem JO; Steen S; Casimir-Ahn H; Granfeldt H; Lönn UJ
    Ann Thorac Surg; 1998 Jun; 65(6):1625-30. PubMed ID: 9647070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes.
    Joyce DL; Southard RE; Torre-Amione G; Noon GP; Land GA; Loebe M
    J Heart Lung Transplant; 2005 Dec; 24(12):2054-9. PubMed ID: 16364849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bridge to transplantation using paracorporeal biventricular assist devices or the syncardia temporary total artificial heart: is there a difference?
    Nguyen A; Pozzi M; Mastroianni C; Léger P; Loisance D; Pavie A; Leprince P; Kirsch M
    J Cardiovasc Surg (Torino); 2015 Jun; 56(3):493-502. PubMed ID: 24429805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation.
    Pisani BA; Mullen GM; Malinowska K; Lawless CE; Mendez J; Silver MA; Radvany R; Robinson JA
    J Heart Lung Transplant; 1999 Jul; 18(7):701-6. PubMed ID: 10452347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factor analysis for bridge to transplantation with the CardioWest total artificial heart.
    Copeland JG; Smith RG; Bose RK; Tsau PH; Nolan PE; Slepian MJ
    Ann Thorac Surg; 2008 May; 85(5):1639-44. PubMed ID: 18442554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost analysis of the Novacor Left Ventricular Assist System as an outpatient bridge to heart transplantation.
    Arabia FA; Smith RG; Jaffe C; Wild JC; Rose DS; Nelson RJ; McClellan DM; Acuna GA; Edling NG; Harrington NK; Rabago G; Tsen AC; Arzouman DA; Sethi GK; Copeland JG
    ASAIO J; 1996; 42(5):M546-9. PubMed ID: 8944939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bridge to heart transplantation with left ventricular assist device versus inotropic agents in status 1 patients.
    Sasaki H; Mitchell JD; Jessen ME; Lavingia B; Kaiser PA; Comeaux A; Dimaio JM; Meyer DM
    J Card Surg; 2009; 24(6):756-62. PubMed ID: 19754680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization.
    Stringham JC; Bull DA; Fuller TC; Kfoury AG; Taylor DO; Renlund DG; Karwande SV
    J Heart Lung Transplant; 1999 Feb; 18(2):160-5. PubMed ID: 10194040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of anti-HLA antibody by flow cytometry in patients with a left ventricular assist device is associated with early rejection following heart transplantation.
    DeNofrio D; Rho R; Morales FJ; Kamoun M; Kearns J; Dorozinsky C; Rosengard BR; Acker MA; Loh E
    Transplantation; 2000 Mar; 69(5):814-8. PubMed ID: 10755532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes in sensitized heart transplant patients bridged with ventricular assist devices.
    Kidambi S; Mohamedali B; Bhat G
    Clin Transplant; 2015 Jun; 29(6):499-505. PubMed ID: 25773536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the total artificial heart and ventricular assist device as a bridge to transplantation.
    Pifarre R; Sullivan H; Montoya A; Bakhos M; Grieco J; Foy BK; Blakeman B; Altergott R; Lonchyna V; Calandra D
    J Heart Transplant; 1990; 9(6):638-42; discussion 642-3. PubMed ID: 2277301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience with the Novacor left ventricular assist system as a bridge to cardiac transplantation, including the new wearable system.
    Vetter HO; Kaulbach HG; Schmitz C; Forst A; Uberfuhr P; Kreuzer E; Pfeiffer M; Brenner P; Dewald O; Reichart B
    J Thorac Cardiovasc Surg; 1995 Jan; 109(1):74-80. PubMed ID: 7815810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmapheresis during cardiopulmonary bypass: a proposed treatment for presensitized cardiac transplantation patients.
    Larson DF; Elkund DK; Arabia F; Copeland JG
    J Extra Corpor Technol; 1999 Dec; 31(4):177-83. PubMed ID: 10915474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.